AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
2.780
-0.010 (-0.36%)
Jul 22, 2024, 9:56 AM EDT - Market open
AN2 Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$4.00
Upside
+43.88%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jul 3, 2024 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $2 | Hold | Maintains | $7 → $2 | -28.06% | May 16, 2024 |
JMP Securities | JMP Securities | Hold → Buy Upgrades $6 | Hold → Buy | Upgrades | $6 | +115.83% | Apr 2, 2024 |
Oppenheimer | Oppenheimer | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 1, 2024 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $23 → $7 | Buy → Hold | Downgrades | $23 → $7 | +151.80% | Feb 13, 2024 |
Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
JMP Securities | JMP Securities | Buy Initiates $30 | Buy | Initiates | $30 | +979.14% | Jan 4, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $20 → $24 | Buy | Maintains | $20 → $24 | +763.31% | Mar 30, 2023 |
SVB Leerink | SVB Leerink | Buy Maintains $27 → $25 | Buy | Maintains | $27 → $25 | +799.28% | Nov 14, 2022 |
Evercore ISI Group | Evercore ISI Group | Buy Initiates $25 | Buy | Initiates | $25 | +799.28% | Apr 19, 2022 |
Oppenheimer | Oppenheimer | Buy Initiates $22 | Buy | Initiates | $22 | +691.37% | Apr 19, 2022 |
Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 19, 2022 |